Leuphasyl vs Snap-8
Enkephalin-mimetic cosmetic peptide that reduces expression wrinkles by modulating acetylcholine release at the neuromuscular junction, offering a Botox-like topical alternative.
An advanced 8-amino-acid peptide that relaxes facial muscles from the outside in—think of it as 'Botox in a bottle' that you apply to your skin to smooth expression lines without needles or injections.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Leuphasyl
5–5 %
Snap-8
10–10 %
Frequency
Leuphasyl
Once daily
Snap-8
Once daily
Administration
Leuphasyl
Topical application (serums, creams, ampoules)
Snap-8
Topical application
Cycle length
Leuphasyl
Ongoing/indefinite
Snap-8
Ongoing/indefinite
Onset speed
Leuphasyl
Slow (5+ weeks)
Snap-8
Moderate (1-2 weeks)
Evidence level
Leuphasyl
Moderate human trials (Phase 1-2)
Snap-8
Moderate human trials (Phase 1-2)
Benefit ratings
Wrinkle Reduction
Skin Smoothing
Anti-Aging Prevention
Muscle Relaxation
Compound specifications
Leuphasyl
Molecular formula
C29H39N5O7
Molecular weight
569.65 g/mol
Half-life
Topical application (local activity, systemic half-life not applicable)
Bioavailability
Limited (topical peptide; skin penetration challenged by hydrophilic nature and molecular size)
CAS number
64963-01-5
Snap-8
Molecular formula
C41H70N16O16S
Molecular weight
1075.16 g/mol
Half-life
Topical activity persists 12-24 hours on skin
Bioavailability
Penetrates stratum corneum; reaches viable epidermis with appropriate formulation
CAS number
868844-74-0
Dosing compared
Leuphasyl
Topical
2% Leuphasyl in formulation
Once or twice daily · 4-8 weeks
Lowest concentration shown to give significant wrinkle reduction in cosmetic testing; 2% was the threshold at which measurable improvement appeared over ~2 months of daily use [6].
5% Leuphasyl in formulation
Once or twice daily · At least 4 weeks
Manufacturer in-vivo concentration; 5% Leuphasyl reduced wrinkles ~11% after 28 days, and ~25% (up to 47%) when paired with 5% Argireline [6].
Snap-8
Topical
3-5% of supplied peptide solution in formulation
Once to twice daily · 4 weeks initial trial
Source class: manufacturer recommendation, not peer-reviewed clinical data. Lipotec/Lubrizol recommends 3-10% of supplied peptide solution in formulations [1][2]. No peer-reviewed study has tested any specific concentration of Snap-8 alone in a topical formulation.
10% of supplied peptide solution in formulation
Twice daily · Ongoing use
Source class: manufacturer recommendation, not peer-reviewed clinical data. Lipotec/Lubrizol recommends up to 10% concentration [1][2]. The wrinkle-reduction percentages attributed to this concentration (such as 63%) originate from manufacturer datasheets, not peer-reviewed publications, and have not been independently verified.
Best suited for
Leuphasyl
Expression line reduction
Leuphasyl is particularly well-suited for individuals focused on expression line reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Fine line prevention
Leuphasyl is particularly well-suited for individuals focused on fine line prevention. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Age management
Leuphasyl is particularly well-suited for individuals focused on age management. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Non-invasive wrinkle reduction
Leuphasyl is particularly well-suited for individuals focused on non-invasive wrinkle reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Snap-8
Expression Line Fighters
If you've noticed those lines that form when you smile, frown, or squint are starting to stick around even when your face is relaxed, Snap-8 is designed exactly for this. It works on the muscle-skin connection that creates these dynamic wrinkles.
Botox-Curious but Needle-Shy
Love the idea of smoother skin but not ready for injections? Snap-8 offers a topical alternative that works through a similar mechanism as Botox—just gentler and without the commitment. Perfect for testing the waters of muscle-relaxing anti-aging.
Prevention-Focused Millennials
Starting in your late 20s or early 30s with preventive skincare? Snap-8 can help keep expression lines from becoming permanent fixtures by calming the repetitive muscle movements that eventually etch wrinkles into your skin.
Sensitive Skin Types
Unlike some anti-aging actives that can be harsh, Snap-8 is remarkably well-tolerated. If retinoids make your skin angry or acids cause irritation, peptides like Snap-8 offer effective anti-aging without the drama.
Side effects
Leuphasyl
Common
- Mild discomfort at treatment site
- Mild skin tingling
- Mild redness at application site
Uncommon
- Temporary skin dryness
Serious
- Severe allergic reaction
Snap-8
Common
- Mild tingling sensation
- Temporary redness
- Skin dryness
Uncommon
- Contact irritation
- Skin tightness
Serious
- Allergic reaction
Safety & evidence
Leuphasyl
Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Leuphasyl (Pentapeptide-18) has been studied in cosmetic research for over 15 years. This topical enkephalin-mimetic peptide demonstrates an excellent safety profile in cosmetic formulations, with no reported serious adverse effects in clinical applications. As a topical cosmetic ingredient, it avoids systemic absorption concerns associated with injectable treatments. The peptide is well-tolerated across all skin types including sensitive skin. Individual responses can vary with formulation and concentration, but most effects are manageable with standard cosmetic application protocols.
Contraindications
- Known hypersensitivity to peptides
- Open wounds or broken skin at application site
- Active dermatological infections at application site
Snap-8
Evidence level
Moderate human trials (Phase 1-2)
FDA status
Not FDA approved
Safety overview
No peer-reviewed study has tested Snap-8 (acetyl octapeptide-3) alone for safety or efficacy. The compound has been included in two published multi-component microneedle patch studies, both of which combined it with several other active ingredients. Avcil et al. (2020) tested a hyaluronic acid microneedle patch loaded with acetyl octapeptide-3 plus palmitoyl tripeptide-5, adenosine, and seaweed extracts in a 12-week monocentric trial on the eye area. None of the subjects reported any primary or cumulative skin reactions [1]. Shin et al. (2024) tested a dissolving microneedle patch containing acetyl octapeptide-3, L-ascorbic acid 2-glucoside, and sodium cyclic lysophosphatidic acid in 24 subjects over 28 days (patch vs placebo on opposite eyes). No adverse effects were reported [2]. In both studies, multiple active ingredients were present — adverse effects cannot be attributed to or excluded from Snap-8 specifically. An FDA in vitro study of the related compound acetyl hexapeptide-8 (Argireline, 6 amino acids vs Snap-8's 8) found that the peptide remains mostly in the stratum corneum (0.22% of applied dose in human skin) with none reaching the dermis, supporting low systemic exposure for topical SNARE-interfering peptides [4].
Contraindications
- Known allergy to peptide ingredients
- Active skin infections at application site
- Open wounds or severe skin irritation
- Pregnancy (as a precaution due to limited data)
Which is right for you?
Choose Leuphasyl if...
- Expression line reduction
- Fine line prevention
- Age management
- Non-invasive wrinkle reduction
Choose Snap-8 if...
- Wrinkle reduction
- Expression line smoothing
- Preventive anti-aging
- Non-invasive cosmetic enhancement